News of the WeekScience Policy

Report Faults U.S. Strategy for Nanotoxicology Research

See allHide authors and affiliations

Science  19 Dec 2008:
Vol. 322, Issue 5909, pp. 1779
DOI: 10.1126/science.322.5909.1779a

The U.S. government lacks an effective plan for ensuring the safety of nanotechnology, a new report by the National Research Council (NRC) concludes. The report, released last week, finds that the current plan for coordinating federal research on environmental, health, and safety (EHS) risks of nanotechnology amounts to an ad hoc collection of research priorities from the 25 federal agencies that make up the U.S. National Nanotechnology Initiative (NNI), which coordinates federal nanotech programs. What's needed, it argues, are an overall vision and a plan for how to get there and to come up with the money to do so.

“The current plan catalogs nano-risk research across several federal agencies, but it does not present an overarching research strategy needed to gain public acceptance and realize the promise of nanotechnology,” says David Eaton, an environmental and occupational health scientist at the University of Washington, Seattle, who chaired the committee that wrote the report.

The NRC report marks new movement in what has been a long-running tug of war between the Bush Administration and its critics in Congress, academia, and nongovernmental organizations over how best to ensure nanotechnology's safety. Administration officials have maintained that the agencies funding the research—such as the National Institutes of Health and the Environmental Protection Agency—are best qualified to set their priorities and budgets to ensure nanotech safety. Critics counter that a point person is needed to ensure that coordination takes place. The House Science and Technology Committee passed a bill earlier this year reauthorizing NNI and pushing much of the critics' agenda. But the Administration opposed installing a nano overseer, among other things. The bill was shunted aside by the election and the economic chaos this fall and never came to a vote.

Steady climb.

New products containing nanomaterials continue to rise, despite unknowns.


The new report is something of a vindication, says Andrew Maynard, chief scientist at the Woodrow Wilson International Center for Scholars' Project on Emerging Nanotechnologies in Washington, D.C. “It shows we haven't been out on a limb for the last few years,” Maynard says. Maynard has long criticized coordination of EHS research under NNI and served on the NRC panel that wrote the report. “Now the government needs to decide who needs to do what risk research and where the money is going to come from.”

The current report does not assess the potential toxicity of nanomaterials, which are now found in more than 800 commercial products. Rather, last year, the U.S. National Nanotechnology Coordination Office (NNCO), which oversees day-to-day coordination of nanotechnology programs between U.S. federal agencies, asked NRC to evaluate its current EHS research strategy. A statement from NNCO called the development of a broader national strategy “a worthy goal.” However, it says the report's call for reengineering how the federal government oversees NNI “was not within the scope of the NRC panel review, and would require extensive review and analysis and Congressional oversight.”

The back and forth will resume next year. Bart Gordon (D-TN), who chairs the House Science and Technology Committee, said last week that he will reintroduce the bill to reauthorize NNI, which will again put these issues front and center. The key will be whether the new Obama Administration sides with its predecessors or with their critics.

Navigate This Article